お知らせ • Feb 26
Pacífico Compañía de Seguros y Reaseguros, Annual General Meeting, Mar 24, 2026 Pacífico Compañía de Seguros y Reaseguros, Annual General Meeting, Mar 24, 2026, at 12:30 SA Pacific Standard Time. Location: held remotely via zoom, Peru Valuation Update With 7 Day Price Move • Dec 23
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to S/41.30, the stock trades at a trailing P/E ratio of 9.2x. Average trailing P/E is 8x in the Insurance industry in South America. Total returns to shareholders of 104% over the past three years. New Risk • Dec 17
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Peruvian stocks, typically moving 4.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company. お知らせ • Apr 05
Pacífico Compañía de Seguros y Reaseguros announces Annual dividend, payable on June 05, 2025 Pacífico Compañía de Seguros y Reaseguros announced Annual dividend of PEN 2.5600 per share payable on June 05, 2025, ex-date on May 19, 2025 and record date on May 20, 2025. お知らせ • Mar 15
Pacífico Compañía de Seguros y Reaseguros (BVL:PACIFIC1) completed the acquisition of remaining 50% stake in Private Medical Insurance Business in Peru from Banmédica S.A. Pacífico Compañía de Seguros y Reaseguros (BVL:PACIFIC1) agreed to acquire an remaining 50% stake in Private Medical Insurance Business in Peru from Banmédica S.A. on October 31, 2024. By virtue of this acquisition, Banmedica will transfer its 50% interest in the private medical insurance business in Peru to Pacifico Seguros. In addition, Banmedica will transfer its 50% interest in Pacífico S.A. Entidad Prestadora de Salud (“Pacifico EPS”), which runs the corporate health insurance for employees and medical services businesses in Peru, to Credicorp’s subsidiary Grupo Crédito S.A. Upon completion of the transaction, the partnership will be terminated and Credicorp, through its subsidiaries Grupo Crédito S.A. and Pacifico Seguros, will become the sole owner of both the private medical insurance business and Pacifico EPS. Following the transaction, customers, policyholders, agents, and other stakeholders will experience seamless continuity, with no disruptions. No changes in terms, service, or policy administration are expected. Closing is subject to regulatory approvals and other customary closing conditions.
Pacífico Compañía de Seguros y Reaseguros (BVL:PACIFIC1) completed the acquisition of remaining 50% stake in Private Medical Insurance Business in Peru from Banmédica S.A. on March 13, 2025. The transaction has received all necessary regulatory approvals and met closing conditions. お知らせ • Feb 27
Pacífico Compañía de Seguros y Reaseguros, Annual General Meeting, Mar 25, 2025 Pacífico Compañía de Seguros y Reaseguros, Annual General Meeting, Mar 25, 2025, at 11:30 SA Pacific Standard Time. Location: held remotely, Peru Reported Earnings • Oct 31
Third quarter 2024 earnings released: EPS: S/1.29 (vs S/1.29 in 3Q 2023) Third quarter 2024 results: EPS: S/1.29 (down from S/1.29 in 3Q 2023). Revenue: S/1.25b (up 15% from 3Q 2023). Net income: S/187.6m (flat on 3Q 2023). Profit margin: 15% (down from 17% in 3Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 61% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings. Reported Earnings • Jul 18
Second quarter 2024 earnings released: EPS: S/1.18 (vs S/1.58 in 2Q 2023) Second quarter 2024 results: EPS: S/1.18 (down from S/1.58 in 2Q 2023). Revenue: S/1.18b (up 2.2% from 2Q 2023). Net income: S/171.8m (down 20% from 2Q 2023). Profit margin: 14% (down from 19% in 2Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 76% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings. New Risk • May 19
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 13% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Short dividend paying track record (1 year of continuous dividend payments). Shareholders have been diluted in the past year (13% increase in shares outstanding). Reported Earnings • Apr 01
Full year 2023 earnings released: EPS: S/5.37 (vs S/4.06 in FY 2022) Full year 2023 results: EPS: S/5.37 (up from S/4.06 in FY 2022). Revenue: S/4.57b (up 17% from FY 2022). Net income: S/695.3m (up 32% from FY 2022). Profit margin: 15% (up from 13% in FY 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 79% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings. Reported Earnings • Feb 02
Full year 2023 earnings released: EPS: S/5.43 (vs S/4.06 in FY 2022) Full year 2023 results: EPS: S/5.43 (up from S/4.06 in FY 2022). Revenue: S/4.51b (up 15% from FY 2022). Net income: S/695.3m (up 32% from FY 2022). Profit margin: 15% (up from 13% in FY 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 79% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings. Reported Earnings • Oct 28
Third quarter 2023 earnings released: EPS: S/1.48 (vs S/1.34 in 3Q 2022) Third quarter 2023 results: EPS: S/1.48 (up from S/1.34 in 3Q 2022). Revenue: S/1.12b (up 13% from 3Q 2022). Net income: S/188.8m (up 10% from 3Q 2022). Profit margin: 17% (in line with 3Q 2022). Over the last 3 years on average, earnings per share has increased by 64% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth. Reported Earnings • Jul 20
Second quarter 2023 earnings released: EPS: S/1.58 (vs S/0.87 in 2Q 2022) Second quarter 2023 results: EPS: S/1.58 (up from S/0.87 in 2Q 2022). Revenue: S/1.17b (up 25% from 2Q 2022). Net income: S/215.6m (up 118% from 2Q 2022). Profit margin: 19% (up from 11% in 2Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth. Reported Earnings • Jan 27
Full year 2022 earnings released: EPS: S/4.43 (vs S/1.02 loss in FY 2021) Full year 2022 results: EPS: S/4.43 (up from S/1.02 loss in FY 2021). Revenue: S/3.86b (up 3.9% from FY 2021). Net income: S/526.2m (up S/656.6m from FY 2021). Profit margin: 14% (up from net loss in FY 2021). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings. Board Change • Nov 16
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 5 non-independent directors. Independent Director Victoria De La Torre was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Oct 28
Third quarter 2022 earnings released: EPS: S/1.44 (vs S/0.42 in 3Q 2021) Third quarter 2022 results: EPS: S/1.44 (up from S/0.42 in 3Q 2021). Revenue: S/994.4m (up 7.6% from 3Q 2021). Net income: S/171.1m (up 226% from 3Q 2021). Profit margin: 17% (up from 5.7% in 3Q 2021). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 39% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings. Reported Earnings • Jul 28
Second quarter 2022 earnings released: EPS: S/0.84 (vs S/1.30 loss in 2Q 2021) Second quarter 2022 results: EPS: S/0.84 (up from S/1.30 loss in 2Q 2021). Revenue: S/1.06b (up 25% from 2Q 2021). Net income: S/98.9m (up S/279.2m from 2Q 2021). Profit margin: 9.3% (up from net loss in 2Q 2021). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 59% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings. Board Change • Apr 27
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 5 non-independent directors. Independent Director Victoria De La Torre was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Jan 22
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Full year 2021 results: S/1.02 loss per share (down from S/2.15 profit in FY 2020). Revenue: S/3.76b (up 13% from FY 2020). Net loss: S/130.3m (down 150% from profit in FY 2020). Revenue was in line with analyst estimates. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 67 percentage points per year, which is a significant difference in performance. Reported Earnings • Jul 24
Second quarter 2021 earnings released: S/1.49 loss per share (vs S/0.65 profit in 2Q 2020) The company reported a soft second quarter result with weaker earnings and weaker control over costs, although revenues improved. Second quarter 2021 results: Revenue: S/896.9m (up 9.8% from 2Q 2020). Net loss: S/180.3m (down 302% from profit in 2Q 2020). Over the last 3 years on average, earnings per share has fallen by 31% per year but the company’s share price has remained flat, which means it is well ahead of earnings. Upcoming Dividend • Apr 14
Inaugural dividend of S/1.85 per share Eligible shareholders must have bought the stock before 20 April 2021. Payment date: 05 May 2021. This is the first dividend for Pacífico Compañía de Seguros y Reaseguros since going public. The average dividend yield among industry peers is 5.5%. Reported Earnings • Jan 28
Full year 2020 earnings released: EPS S/2.79 (vs S/4.13 in FY 2019) The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: S/3.41b (up 3.3% from FY 2019). Net income: S/313.0m (down 33% from FY 2019). Profit margin: 9.2% (down from 14% in FY 2019). The decrease in margin was driven by higher expenses. Valuation Update With 7 Day Price Move • Nov 13
Market bids up stock over the past week After last week's 18% share price gain to S/35.00, the stock is trading at a trailing P/E ratio of 10.2x, up from the previous P/E ratio of 8.6x. This compares to an average P/E of 7x in the Insurance industry in Peru. Total returns to shareholders over the past year are 18%. Is New 90 Day High Low • Nov 13
New 90-day high: S/35.00 The company is up 18% from its price of S/29.59 on 14 August 2020. The Peruvian market is down 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Insurance industry, which is flat over the same period. Reported Earnings • Nov 02
Third quarter 2020 earnings released: EPS S/0.53 The company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2020 results: Revenue: S/800.2m (down 1.7% from 3Q 2019). Net income: S/49.7m (down 57% from 3Q 2019). Profit margin: 6.2% (down from 14% in 3Q 2019). The decrease in margin was primarily driven by higher expenses.